Literature DB >> 11489868

Diversity of Streptococcus salivarius ptsH mutants that can be isolated in the presence of 2-deoxyglucose and galactose and characterization of two mutants synthesizing reduced levels of HPr, a phosphocarrier of the phosphoenolpyruvate:sugar phosphotransferase system.

S Thomas1, D Brochu, C Vadeboncoeur.   

Abstract

In streptococci, HPr, a phosphocarrier of the phosphoenolpyruvate:sugar phosphotransferase transport system (PTS), undergoes multiple posttranslational chemical modifications resulting in the formation of HPr(His approximately P), HPr(Ser-P), and HPr(Ser-P)(His approximately P), whose cellular concentrations vary with growth conditions. Distinct physiological functions are associated with specific forms of HPr. We do not know, however, the cellular thresholds below which these forms become unable to fulfill their functions and to what extent modifications in the cellular concentrations of the different forms of HPr modify cellular physiology. In this study, we present a glimpse of the diversity of Streptococcus salivarius ptsH mutants that can be isolated by positive selection on a solid medium containing 2-deoxyglucose and galactose and identify 13 amino acids that are essential for HPr to properly accomplish its physiological functions. We also report the characterization of two S. salivarius mutants that produced approximately two- and threefoldless HPr and enzyme I (EI) respectively. The data indicated that (i) a reduction in the synthesis of HPr due to a mutation in the Shine-Dalgarno sequence of ptsH reduced ptsI expression; (ii) a threefold reduction in EI and HPr cellular levels did not affect PTS transport capacity; (iii) a twofold reduction in HPr synthesis was sufficient to reduce the rate at which cells metabolized PTS sugars, increase generation times on PTS sugars and to a lesser extent on non-PTS sugars, and impede the exclusion of non-PTS sugars by PTS sugars; (iv) a threefold reduction in HPr synthesis caused a strong derepression of the genes coding for alpha-galactosidase, beta-galactosidase, and galactokinase when the cells were grown at the expense of a PTS sugar but did not affect the synthesis of alpha-galactosidase when cells were grown at the expense of lactose, a noninducing non-PTS sugar; and (v) no correlation was found between the magnitude of enzyme derepression and the cellular levels of HPr(Ser-P).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11489868      PMCID: PMC95391          DOI: 10.1128/JB.183.17.5145-5154.2001

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  51 in total

Review 1.  Regulation of the pts operon in low G+C Gram-positive bacteria.

Authors:  C Vadeboncoeur; M Frenette; L A Lortie
Journal:  J Mol Microbiol Biotechnol       Date:  2000-10

2.  Characterization of Escherichia coli strains producing heat-stable enterotoxin b (STb) isolated from humans with diarrhea.

Authors:  L A Lortie; J D Dubreuil; J Harel
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

3.  Quantitative determination of the intracellular concentration of the various forms of HPr, a phosphocarrier protein of the phosphoenolpyruvate: sugar phosphotransferase system in growing cells of oral streptococci.

Authors:  C Vadeboncoeur; D Brochu; J Reizer
Journal:  Anal Biochem       Date:  1991-07       Impact factor: 3.365

4.  Determination of total protein.

Authors:  G L Peterson
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

5.  Control of sugar utilization in oral streptococci. Properties of phenotypically distinct 2-deoxyglucose-resistant mutants of Streptococcus salivarius.

Authors:  L Gauthier; S Bourassa; D Brochu; C Vadeboncoeur
Journal:  Oral Microbiol Immunol       Date:  1990-12

6.  Control of sugar utilization in the oral bacteria Streptococcus salivarius and Streptococcus sanguis by the phosphoenolpyruvate: glucose phosphotransferase system.

Authors:  C Vadeboncoeur; G Bourgeau; D Mayrand; L Trahan
Journal:  Arch Oral Biol       Date:  1983       Impact factor: 2.633

7.  The presence of two forms of the phosphocarrier protein HPr of the phosphoenolpyruvate:sugar phosphotransferase system in streptococci.

Authors:  D Robitaille; L Gauthier; C Vadeboncoeur
Journal:  Biochimie       Date:  1991-05       Impact factor: 4.079

8.  Structure and properties of the phosphoenolpyruvate: glucose phosphotransferase system of oral streptococci.

Authors:  C Vadeboncoeur
Journal:  Can J Microbiol       Date:  1984-04       Impact factor: 2.419

9.  Xylitol-mediated transient inhibition of ribitol utilization by Lactobacillus casei.

Authors:  J London; S Hausman
Journal:  J Bacteriol       Date:  1982-05       Impact factor: 3.490

10.  Regulation of glycolysis and sugar phosphotransferase activities in Streptococcus lactis: growth in the presence of 2-deoxy-D-glucose.

Authors:  J Thompson; B M Chassy
Journal:  J Bacteriol       Date:  1983-05       Impact factor: 3.490

View more
  3 in total

Review 1.  How phosphotransferase system-related protein phosphorylation regulates carbohydrate metabolism in bacteria.

Authors:  Josef Deutscher; Christof Francke; Pieter W Postma
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

2.  The doubly phosphorylated form of HPr, HPr(Ser~P)(His-P), is abundant in exponentially growing cells of Streptococcus thermophilus and phosphorylates the lactose transporter LacS as efficiently as HPr(His~P).

Authors:  Armelle Cochu; Denis Roy; Katy Vaillancourt; Jean-Dominique Lemay; Israël Casabon; Michel Frenette; Sylvain Moineau; Christian Vadeboncoeur
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

3.  Phosphorylation of Streptococcus salivarius lactose permease (LacS) by HPr(His ~ P) and HPr(Ser-P)(His ~ P) and effects on growth.

Authors:  Christian Lessard; Armelle Cochu; Jean-Dominique Lemay; Denis Roy; Katy Vaillancourt; Michel Frenette; Sylvain Moineau; Christian Vadeboncoeur
Journal:  J Bacteriol       Date:  2003-12       Impact factor: 3.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.